Fertility Preservation in Cancer Patients

Submitted by PatientsEngage on 13 August 2017

Dr Shruti Mohanka, a fertility specialist and gynaecologist at Global hospital in Mumbai helps us understand how fertility preservation should addressed for all young male and female patients undergoing cancer treatment.

Fertility preservation is a critical element of improving quality of life in cancer survivors. Young children and young adults often survive cancer and may wish to have families in the future. They and their families need to be aware that preserving fertility is an option. Too often they are either too overwhelmed or too embarrassed to discuss this with their doctor. This is a discussion they must have with their medical team BEFORE the treatment begins.   

1.    Is fertility discussed with all cancer patients undergoing treatment? When is such a discussion essential?

Fertility should be discussed with all patients undergoing cancer treatment. It is imperative that fertility preservation be performed prior to initiation of cancer therapy.

2.    Which treatments and which cancers affect fertility?

Any cancer treatment that requires radiation therapy can affect a woman’s fertility. In case of reproductive cancers like ovarian and uterine cancers, surgery in the affected area can also affect chances of reproduction. 

(Bladder, Rectal, Testicular cancers are some of the cancers that affect male fertility) 

3.    What age groups are excluded from such a discussion?

Post-menopausal women, and men who have completed their family are excluded from such a discussion. Even pre-pubertal children can have their ova and sperm retrieved and stored.

4.    What fertility preservation options are available for males?

For males, fertility preservation options include semen or sperm cryopreservation. Semen cryopreservation is commonly called sperm banking or freezing. It is a procedure in which sperm is deposited, frozen and stored for either a short term(less than a year) or long term (indefinitely). The sample is screened for certain infections such as HIV, Syphilis, HTLV-1 and Hepatitis. Sperm is usually mixed with liquid nitrogen and secured at temperature of less than -196oC. This sperm can then be used in the future for IVF, artificial insemination or fertility treatment procedures.

In men, who have reproductive cancers or are unable to ejaculate sperm, sperm retrieval may be required. Testicular sperm aspiration or TESA is done with a fine needle inserted into the testicle. A percutaneous biopsy may also be done for some patients which uses a large needle and extracts more sperm.

5.    What fertility preservation options are available for females?

Fertility preservation options for females include:

  1. Egg Freezing is a standard storage method for oocytes or ova. For breast cancer patients, a medication is used to lower the estrogen levels temporarily to stimulate egg collection.
  2. Embryo freezing requires a male partner or sperm donor and takes about 2-6 weeks. It has shown to have high pregnancy rates of 59%.
  3. Ovarian tissue freezing is done for pre-pubertal girls where primordial cells are retrieved and stored.
  4. Ovarian transposition is considered for patients receiving radiation therapy to the pelvis. To prevent the ovary from the effects of radiation, it is moved to the posterior fossa via surgery.
  5. Ovarian suppression involves blocking hormones that stimulate the ovaries so that egg maturation is prevented. This is done via a medication called leuprolide.
  6. Radical Trachelectomy is the removal of the cervix and not the uterus in patients with cervical cancer. This can however increase risk of pre-term birth in future pregnancies.

6.    What are future risks of fertility preservation?

In less than 1% of cases there may be a chance of tumor cells transmitted to the ovum or sperm. To avoid any such risks, a Preimplantation Genetic Test (PGT) is done on the embryo prior to implantation to detect any abnormality.

7.    What is the average length of time for storage of ovum and sperm?

Sperm and ova can be stored for either a short term(less than a year) or long term (indefinitely).
Embryo can be frozen for 10 years.

8.    Are spouses or patients provided with counselling options?

The complete counseling is done by the doctors themselves with in-depth explanation of fertility preservation options. Most consults are done with the spouse present. For underage children (below 18 years of age), parental consent is essential.

9.    How expensive are cold storage facilities or cyropreservation?

Charges for cryopreservation vary from lab to lab but approximately it is:

Rs 25,000 for ovum collection/retrieval,
Rs 5,000 per year for ovum preservation.
Rs 5,000 per year for sperm preservation and
Rs 10,000 per year for embryo preservation.

Dr Shruti Mohanka is a fertility specialist and gynaecologist at Global hospital in Mumbai 

Community
Women's Health and Pregnancy
Cancer
Condition
Breast Cancer
Cancer
Ovarian Cancer

Stories

  • Don't Believe the Hype - 10 Persistent Cancer Myths Debunked
    Driven by the evidence, not by rhetoric or anecdote, we describe what the reality of research actually shows to be true. Myth 1: Cancer is a man-made, modern disease While it’s certainly true that global lifestyle-related diseases like cancer are on the rise, the biggest risk factor for cancer is age. Myth 2: Superfoods prevent cancer Blueberries, beetroot, broccoli, garlic, green tea… the list goes on. Despite thousands of websites claiming otherwise, there’s no such thing…
  • Cambridge University finds gene behind killer disease - Triple negative breast cancer
    Triple-negative breast cancer is one of the most deadly forms of the disease, does not respond to hormonal therapies such as tamoxifen, or targeted drugs like Herceptin and nearly one quarter of patients diagnosed will not survive for more than five years. Now researchers at Cambridge University and the Wellcome Trust’s Sanger Institute have found that the BCL11A gene is overactive in eight out of ten patients. The study opens the door for therapies which suppress the gene and…
  • Goodbye Year of Cancer. Hello Hope!
    Death stared at me up close this year, says cancer survivor Minakshi Ray. What did that teach her about life? As I sit back and take stock of how 2014 treated me, I would say, it was a mixed bag. There have been losses and gains. I don't mean material losses or gains, rather I will remember the year in terms of the emotional journey. Following my battle of survival against breast cancer, my perspective on life has changed completely. The biggest realisation that has dawned…
  • Ovarian cancer
    What is ovarian cancer Ovarian cancer is cancer that develops in one or both the ovaries. It can then spread to other parts of the body. Cancer in the ovaries can also be a secondary cancer, the result of metastasis from a primary cancer elsewhere in the body. 7% of ovarian cancers are due to metastases while the rest are primary cancers that occur in the ovaries itself. Cancer occurring primarily in breast or in gastrointestintinal tract most often tend to metastasise to the ovaries. Ovarian…
  • Cancer survival rate in India among the lowest in the world
    Michael Coleman, professor at the London School of Hygiene and Tropical Medicine, and one of the lead authors of the study told TOI that one reason for the low survival rates in India could be that equitable access to early diagnosis and optimal treatment is not yet available for all people in India. "Some of the most advanced medical facilities in the world can be found in Mumbai (for example), but they are out of reach of the vast majority of the Indian population," he said. "The inequality…
  • How the promise of Immunotherapy is transforming Oncology
    Nine years later, against all odds, Mr. Telford is still alive. What saved him was an experimental immunotherapy drug—a medication that unleashes the body’s own immune system to attack cancer. His remarkable survival caught the attention of researchers, who began to realize that the way immunotherapy drugs were affecting tumors was unlike almost anything seen with conventional treatments. Today Mr. Telford is among a growing group of super-survivors who are transforming the world of…
  • 43% of Heart Attack Patients Had Anaemia
    India and South-east Asia has high incidence of anaemia. Family practitioner Dr Gita Mathai tells you all you need to know about this often-silent threat that can pose many complications.  What is anaemia? Anaemia (or Anemia) is a generic term for low haemoglobin in the blood from any cause. It is not a disease by itself. It can occur in different forms and be caused by many factors.  Anaemia is diagnosed when the haemoglobin value checked in the laboratory is…
  • Ananda Shankar Jayant : I want to be known not as a cancer survivor, but as a cancer conqueror
    Ananda Shankar Jayant talks of what inspired and gaver her strength to deal with Breast Cancer, its treatment, its aftermath "I realized then that I, who thought I had complete control of my life, had control of only three things: My thought, my mind -- the images that these thoughts created -- and the action that derived from it.  And I found that in my dance, my dance, my strength, my energy, my passion, my very life breath. But it wasn't easy. Believe me, it definitely wasn't easy…
  • Foods that fight cancer
    By nutritionist Kohila Govindaraju Being overweight has been linked with the increased risk of breast cancer, endometrial (uterus), and colorectal cancer. So keep your BMI at 25 or less with these foods that reduce your waist and your cancer risk: Fruits, vegetables, wholegrains and pulses are rich in vitamins and minerals, boosting your immune system. Go for dark coloured beans (rajma, brown beans, green beans, black-eyed beans) and brightly coloured vegetables and…
  • CYRAMZA now approved both as a single-agent treatment and in combination with chemotherapy
    The U.S. Food and Drug Administration (FDA) has approved CYRAMZA® (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy. CYRAMZA now has two FDA approvals for these patients. Today's announcement follows the April approval of CYRAMZA as a…